Theraclion SA (TCLIF)
OTCMKTS · Delayed Price · Currency is USD
0.3200
+0.3198 (159,900.00%)
At close: Aug 26, 2024
Theraclion Company Description
Theraclion SA provides therapeutic ultrasound equipment.
It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality.
The company was incorporated in 2004 and is headquartered in Malakoff, France.
Theraclion SA
| Country | France |
| Founded | 2004 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Martin Deterre |
Contact Details
Address: 244, avenue Pierre Brossolette Malakoff, 92240 France | |
| Phone | 33 1 55 48 90 70 |
| Website | theraclion.com |
Stock Details
| Ticker Symbol | TCLIF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010120402 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Martin Deterre | GM and Chief Executive Officer |
| Yann M. Duchesne | Executive Chairman |
| Christophe Lamboeuf | Chief Financial Officer |
| Gaylord Tallec | Vice President of Operations |
| Jérémie Anquez | Vice President Research and Chief Scientific Officer |